
==== Front
World J Orthop
WJO
World Journal of Orthopedics
2218-5836
Baishideng Publishing Group Inc

jWJO.v15.i9.pg841
10.5312/wjo.v15.i9.841
98577
Minireviews
Impacts of radiation therapy on quality of life and pain relief in patients with bone metastases
Hoveidaei et al. RT on QoL and pain relief in BM
Hoveidaei Armin Students’ Scientific Research Center, Exceptional Talents Development Center, Tehran University of Medical Sciences, Tehran 1416753955, Iran

Karimi Mehdi Bogomolets National Medical University, Kyiv 01601, Ukraine

Khalafi Vida Student Research Committee, Jahrom University of Medical Sciences, Jahrom 7413188941, Iran

Fazeli Patrick Brown University, Providence, RI 02912, United States

Hoveidaei Amir Human International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, MD 21215, United States. hoveidaei.a.h@gmail.com

Author contributions: All authors participated in the conception and primary drafting of the manuscript; Hoveidaei AH focused on conception and made critical revisions to the manuscript; Fazeli P contributed to the research as an individual consultant without using Brown University’s resources; All authors have read and approved the final version of the manuscript.

Corresponding author: Amir Human Hoveidaei, MD, Research Fellow, International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, 2401 West Belvedere Avenue, Baltimore, MD 21215, United States. hoveidaei.a.h@gmail.com

18 9 2024
18 9 2024
15 9 841849
29 6 2024
31 7 2024
15 8 2024
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
2024
https://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
Bone metastases (BM) are a common complication in advanced cancer patients, significantly contributing to morbidity and mortality due to their ability to cause pain, fractures, and spinal cord compression. Radiation therapy (RT) is vital in managing these complications by targeting metastatic lesions to ease pain, improve mobility, and reduce the risk of skeletal-related events such as fractures. Evidence supports the effectiveness of RT in pain relief, showing its ability to provide significant palliation and lessen the need for opioid painkillers, thereby enhancing the overall quality of life (QoL) for patients with BM. However, optimizing RT outcomes involves considerations such as the choice of radiation technique, dose fractionation schedules, and the integration of supportive care measures to mitigate treatment-related side effects like fatigue and skin reactions. These factors highlight the importance of personalized treatment planning tailored to individual patient needs and tumor characteristics. This mini-review aims to provide comprehensive insights into the multifaceted impacts of RT on pain management and QoL enhancement in BM patients, with implications for refining clinical practices and advancing patient care through the synthesis of findings from various studies.

Radiation therapy
Radiotherapy
Quality of life
Pain relief
Bone metastases
Bone cancer
==== Body
pmc Core Tip: Radiation therapy (RT) significantly alleviates pain and improves quality of life in patients with bone metastases. Optimizing RT effectiveness involves personalized treatment approaches and supportive care measures to manage side effects, enhancing overall well-being and symptom control.

INTRODUCTION

Brief overview of bone metastasis and its impact on quality of life

Cancers are a significant global problem and may lead to severe complications like bone metastasis (BM), which can cause pain and mobility issues[1,2]. Additionally, the psychological impact of cancer can be profound, resulting in anxiety and depression for many patients[3]. Metastatic bone cancer, or secondary bone cancer, denotes the proliferation of tumors originating from other tissues and disseminating (metastasizing) to bone sites[4]. According to the American Cancer Society, about 400000 new malignant BM cases are diagnosed annually[5]. The incidence rate of BM in the United States is still unknown, with estimates varying from 21000 to 400000 per annum[6]. BM ranks as the third most prevalent site for metastatic malignancies[7]. Notably, bone represents a common locus for metastases, often signaling a short prognosis for cancer patients. Indeed, BM surpasses primary bone cancers in occurrence, particularly among adults[8]. Among cancers, prostate cancer poses the highest risk for bone metastases, trailed by lung, renal, or breast cancers. The rich arterial supply to bone predisposes it to metastatic dissemination[9,10]. Generally, the presence of BM in patients predicts a poor prognosis, with median survival ranging from 6 months to 4 years, depending on the primary cancer type[8]. It can significantly impact the quality of life (QoL), causing severe pain, impaired mobility, pathological fractures, spinal cord compression, and other complications[8,11]. It negatively affects multiple domains of QoL, including physical, emotional, social, and functional well-being[11]. Pain is a significant factor impacting QoL, but other issues like reduced activities of daily living also play an essential role[11,12]. Treatment aims to relieve pain, prevent complications, and improve overall QoL. Options include pain medications, radiation therapy (RT), surgery, and bone-targeted agents like bisphosphonates[12]. In general, a multidisciplinary approach involving oncologists, pain specialists, radiologists, orthopedic surgeons, and others is recommended for optimal management[8,12].

Introduction to radiotherapy as a treatment option for bone metastasis

RT is the predominant therapeutic approach for addressing painful bone metastases in the spine and non-spine regions. Initially, conventional low-dose external beam RT was employed for this purpose; however, stereotactic body radiotherapy (SBRT) is increasingly utilized for such cases[13]. The SBRT technique employed by Correia et al[14] involved a variable dosing regimen (range 24-42Gy) administered in 2 to 7 separate fractions. Other studies utilized SBRT using variable dosing regimens, ranging from 15-24 Gy in a single fraction to 24 to 50 Gy delivered over 3 to 5 fractions. These studies reported local control rates of approximately 90% with a decreased incidence of adverse effects[15]. The principal aim of RT in managing BM is to alleviate pain and enhance the QoL for patients[16]. This treatment modality assumes critical importance due to the array of challenges posed by bone metastatic disease, encompassing pain, fractures, spinal cord compression, and neurological deficits[16]. Notably, RT assumes a pivotal role in pain management and overall QoL enhancement for individuals with BM[16]. In uncomplicated bone metastases, defined by the absence of pathological fractures, evidence of cord compression, or previous surgical interventions, RT has demonstrated notable efficacy, with improvements or complete pain relief observed in up to 60% of cases. Moreover, there appears to be no discernible difference in effectiveness between single or multiple-fraction RT regimens[17].

Purpose of the mini-review

Our purpose in this mini-review study was to offer a thorough investigation of the effects of RT on pain alleviation and QoL among patients with bone metastases. This involved synthesizing available evidence concerning the effectiveness of RT in managing pain associated with BM and its influence on various aspects of patient’s QoL. Ultimately, our goal was to provide clinicians and researchers with valuable insights to improve the application of RT in treating bone metastases, focusing on enhancing overall well-being and symptom control for patients (Figure 1).

Figure 1 The impact of radiation therapy in bone metastasis patients on the quality of life.

EFFECTS OF RADIOTHERAPY ON PAIN RELIEF

Summary of studies demonstrating the efficacy of radiotherapy in reducing pain in patients with bone metastasis

Prior research has shown that conventional RT alleviates pain in approximately 60% of people suffering from painful bone metastases, with total pain reduction in about 30% of cases[18,19]. On the other hand, SBRT is a more precise RT technique delivering high doses of radiation in few fractions, primarily used for extra-cranial lesions like lung, liver, and prostate, offering enhanced accuracy compared to conventional radiotherapy (cRT)[20]. SBRT also demonstrated a pain relief rate reaching up to 50%[21]. In a study conducted by Wang et al[22] they revealed that patients undergoing SBRT had better pain alleviation three months after radiation than those undergoing cRT, with no increase in adverse event occurrence. Moreover, in a study on palliative RT fractionation for bone metastases, Rich et al[23] discovered that both single and multiple-fraction radiation treatment regimens consistently result in similar pain management and side effects. However, patients who receive single-fraction treatment are more likely to require re-treatment.

Discussion of the mechanisms by which radiotherapy alleviates pain

The exact mechanism underlying radiation-induced pain alleviation remains unexplained. Radiation's analgesic impact is thought to be due to a variety of causes, including ossification stimulation, osteoclast activity inhibition within the bone microenvironment, and cancer cell elimination, all of which lead to decreased osteolysis and, as a result, tumor burden reduction[24,25]. Some patients have immediate pain relief that lasts longer than 24 hours, indicating a decrease in inflammatory cell activity and the concentration of chemical pain mediators in the radiation-exposed area. These characteristics help to increase the analgesic efficacy of RT[26]. The fractionation regimen of RT used on individuals with BM impacts the degree of mineralization, bone density, and re-calcification at the treated location, which correlates with pain response[27,28].

Impact of pain relief on quality of life in patients with bone metastasis

Patients with bone pain frequently face increasing difficulties completing daily activities, which is accompanied by severe distress and a reduction in QoL. Despite this, few studies provide complete QoL assessments. Furthermore, existing research provides mixed results, and some show an improvement in QoL among patients who respond well to RT treatment[29-33]. Others suggest that RT's impact on QoL across various domains is inconsistent[34-36]. Nevertheless, a recent study conducted by Mendez et al[34] discovered that patients over 75 significantly improved overall activity, mood, and interpersonal interactions more than their younger counterparts. Furthermore, their patients experienced pain relief as early as four weeks after getting RT. This finding was associated with a statistically significant improvement in QoL across all dimensions of functional interference, except sleeping quality, consistent with Zeng et al[37] results. On the other hand, Khan et al[38] claimed that sleeping improves in the second and third month after the treatment in patients responding positively to the RT.

EFFECTS OF RADIOTHERAPY ON PHYSICAL FUNCTIONING

Review of research on how radiotherapy affects physical functioning in patients with bone metastasis

Studies have demonstrated the substantial impact of RT on the physical functioning and QoL of individuals with BM[15]. The primary goal of RT in this context is to alleviate pain and prevent skeletal-related events such as fractures, which can severely impact a patient's mobility and daily activities. while RT is beneficial for pain management and may contribute to improved physical functioning, a comprehensive approach considering all influencing factors is necessary for optimal patient care[39].

A prospective, single-institutional study showed that RT significantly improved nine domains of QoL in patients with BM, with pain management the most notable improvement. This study underscored the effectiveness of RT in palliating painful BM and enhancing QoL[40]. Patients with bone metastases receiving palliative radiotherapy have reported improvements in their physical functioning, including general activities of daily living[11,41]. A study found that gender, performance status, and primary histology affect health-related QoL in patients with BM[42].

Discussion of improvements in mobility, daily activities, and overall physical well-being following radiotherapy

RT, particularly when integrated with complementary therapeutic modalities, enhances daily functioning, mobility, and overall physical well-being among patients with BM[43]. Its pivotal role in managing BM chiefly revolves around pain alleviation, indirectly fostering improved mobility, daily activities, and overall physical wellness. RT exhibits efficacy in providing pain relief for patients with BM originating from diverse primary cancers, including lung, breast, colon, and prostate, among others[44-48]. Augmenting RT with adjunctive interventions like Poly methyl methacrylate acetabuloplasty or pharmacological approaches such as calcitonin can increase these outcomes[49]. This body of research underscores the necessity of adopting a multidisciplinary approach to managing BM to optimize physical function and enhance the QoL for affected patients[49].

Consideration of the long-term effects on physical functioning

Although there is no investigation to provide specific results on the long-term impact of RT on physical functioning, studies suggest that by effectively managing symptoms and complications related to BM through RT and supportive care, patients may experience maintenance or improvement in physical functioning and overall QoL[41]. A primary consideration associated with RT for BM revolves around the possibility of long-term bone impairment and heightened fracture susceptibility. Radiation exposure can induce bone demineralization and debilitation, particularly within irradiated regions, consequently elevating the likelihood of pathological fractures. Such fractures can exacerbate limitations in physical functioning and mobility[50].

Combining RT with bone-targeted therapies may help mitigate the adverse effects on bone health[50]. RT may precipitate enduring musculoskeletal complications, encompassing muscle weakness, joint stiffness, and diminished range of motion. Such effects can be further compounded by the presence of underlying BM and the accompanying pain and immobility[51]. Physical activity and exercise, when possible, may help preserve musculoskeletal function and mitigate some of the adverse effects of RT and BM[51].

EFFECTS OF RADIOTHERAPY ON EMOTIONAL WELL-BEING

Examination of the psychological impact of bone metastasis and associated pain

Patients with BM usually experience psychological distress marked by anxiety, depression, and fear[52,53]. The associated pain, disability, and loss of independence often induce feelings of helplessness, social isolation, and apprehension regarding the future and end-of-life[52,54]. Studies demonstrated that BM exerts a more profound negative impact on psychological well-being compared to other metastatic sites. Multivariate logistic regression indicated that older age, female sex, malignancy, higher numeric rating scale scores, and a lower Barthel Index were associated with increased risk for psychological distress[53]. Weng Hong et al[55] did a study among orthopedic oncology patients and reported that 29.8% had anxiety, 16.2% had depression, and 15.2% had mixed anxiety and depression.

Review of studies showing the positive effects of radiotherapy on emotional well-being and quality of life

Few studies have looked into the psychological effects of RT. For instance, Cañón et al[41] revealed that responders to RT significantly improved functional psychosocial aspects (such as relations with others and life enjoyment) compared with nonresponders. These findings were consistent with Mcdonald et al[33], Westhoff et al[35], and Caissie et al[56] evaluated the emotional functioning of the patients by asking them about feeling tense or depressed, and they found that RT responders had an improvement in emotional functioning together with a decrease in symptoms such as insomnia at month 1.

Discussion of the role of psycho-social support in improving emotional outcomes

Providing psycho-social support for individuals coping with BM is crucial for enhancing their overall well-being and QoL. According to some studies, prognostic awareness correlates with decreased QoL and mood among patients recently diagnosed with incurable cancer[57-60]. Furthermore, some studies show that patients who go through palliative therapy along with their treatment have better outcomes than patients undergoing oncology treatment alone[61,62]. However, specific coping strategies have been examined for their potential to enhance patients' mood and QOL. For instance, acceptance has been shown to positively influence patients' psychological and emotional well-being, diverging from the adverse effects associated with denial and self-blame[63]. This insight could guide the patient's support system, including their family and medical caregivers, in creating the best environment to assist the patient in overcoming this challenge.

FACTORS INFLUENCING QUALITY OF LIFE OUTCOMES

Exploration of factors that may influence the effectiveness of radiotherapy on quality of life in patients with bone metastasis, for instance, the coronavirus disease 2019 lockdown effects on the outcomes

The pandemic of the coronavirus disease 2019 (COVID-19) challenges medical professionals to treat patients with advanced cancers, especially with RT[64]. Cancer patients are known to be fragile, so it is critical to treat patients safely and reduce the transmission risk of COVID-19[64]. Oncologists must re-organize how they approach treatment to reduce pain and improve palliation of patients[64,65]. Palliative RT can dramatically maximize the QoL of patients, even during the COVID-19 pandemic[66]. As such, guidelines recommend that patients with BM receive the 8Gy single-fraction RT during a single hospital visit[64,67]. Hypofractionated regimens for radiation are recommended to reduce the frequency of transport, the number of sessions, and complicated treatments[64].

Consideration of patient characteristics, treatment regimen, and supportive care services

Numerous factors, such as patient characteristics, treatment regimen, and supportive care services, can influence QoL outcomes[31]. Responding patients with painful BM have higher QoL scores than nonresponders after RT[31]. Elderly cancer patients show a worse QoL, including appetite and physical functioning, after RT for BM than younger patients[31,68,69]. Patients with younger ages report significant QoL[68]. More women report clinically better improvement in enjoyment of life and mood after radiation for relieving bone pain[68]. High bone pain scores are associated with poor performance status, influencing functional QoL after RT[35]. Combined hyperthermia and RT significantly improve the QoL and ease bone pain in patients with BM[70]. Nurse-led education reduces pain intensity and improves patient empowerment in cancer patients with BM undergoing RT[71].

Implications for personalized treatment approaches

Treatment recommendations for palliative RT for BM should be personalized based on individual patient characteristics to optimize patient outcomes[72-74]. Considering the patient's life expectancy, overall health, tumor progression, tumor biology, comorbidities, and clinical condition allows for the development of personalized treatment plans[72-74].

FUTURE DIRECTIONS AND CLINICAL IMPLICATIONS

Summary of key findings regarding the effects of radiotherapy on quality of life in patients with bone metastasis

BM significantly impacts patients' physical, functional, and psychosocial QoL[75]. New therapies and interventions have improved patient's QoL and extended life expectancy. RT is the primary therapeutic approach for managing painful bone metastases, playing a crucial role in pain management and improving the overall QoL for individuals with BM[13,16,76].

Studies have shown the efficacy of both cRT and SBRT in relieving pain for patients with BM[22,23]. They indicated that patients undergoing SBRT experienced more pain relief three months after radiation than those undergoing cRT[22]. Radiation's impact is due to multiple factors, including ossification stimulation, osteoclast activity inhibition within the bone microenvironment, and cancer cell elimination[24,25]. These mechanisms lead to decreased osteolysis and reduced tumor burden[24,25]. Pain relief was associated with a statistically significant enhancement in QoL across various aspects of functional interference, except sleeping quality[41]. The main goal of RT is to alleviate pain and prevent skeletal-related events that can severely affect a patient's mobility and daily functioning[39]. RT is valuable for pain management and may positively enhance physical functioning[39]. Integrating RT with complementary therapeutic approaches improves physical well-being, mobility, and daily functioning in patients with BM[43]. RT can cause long-term musculoskeletal complications, including muscle weakness, joint stiffness, and limited movement, compounded by bone metastases, the accompanying pain, and immobility[51]. Research demonstrated that BM has a more profound negative impact on psychological well-being than other sites of metastasis[53]. Cañón et al[41] revealed that individuals who responded positively to RT experienced more improvements in their relationships with others and enjoyment of life than nonresponders.

Discussion of potential areas for further research and improvements in treatment strategies

BM, which is a severe complication of cancer, demands immediate attention as it is indicative of a limited prognosis in individuals with cancer[77,78]. Despite our knowledge being enhanced in the metastatic process, several questions remain unanswered that necessitate further research to comprehend the skeletal consequences of metastasis[78]. Future research directions in RT for BM include several critical areas[79]. These comprise response definitions, refining eligibility criteria, reirradiation, systemic therapy changes, radiation techniques, follow-up parameters, and assessment timing[79]. for instance, SBRT may improve local control and pain relief in non-spine BM individuals. However, further research is essential in areas such as volume delineation, MRI, ideal doses, and fractionation[15].

Recommendations for healthcare providers in optimizing quality of life outcomes for patients undergoing radiotherapy for bone metastasis

Therapeutic interventions have the potential to improve pain control and function and the preservation of skeletal integrity in patients with BM[80]. The approach to treatment necessitates a multidisciplinary approach[80]. Achieving successful management of BM requires collaboration among healthcare professionals such as medical oncologists, surgical oncologists, and radiation oncologists[80]. The judgment of expert radiation oncology physicians is crucial for optimizing outcomes of RT in treating painful BM[72]. Effective RT for BM requires a personalized approach that includes various factors, such as the individual's life expectancy and the progression of tumors in different sites[73].

CONCLUSION

In conclusion, RT has been proven to be a crucial treatment for patients with BM. It significantly helps to relieve pain and improve overall QoL. This treatment approach reduces the intense discomfort often associated with metastatic bone lesions, allowing patients to experience a notable improvement in their daily functioning and well-being. While the primary goal of RT is to manage pain and control disease progression, it's equally important to consider the broader impact on patients' QoL. The physical side effects, psychological stress, and potential long-term consequences of treatment require a comprehensive and patient-centered approach. Healthcare providers should prioritize the clinical effectiveness of RT and the individual patient’s experience, preferences, and overall QoL. By incorporating supportive care measures, personalized treatment plans, and ongoing assessment of QoL outcomes, we can optimize therapeutic regimens and ensure a holistic approach to caring for patients with bone metastases. Ultimately, recognizing and addressing these multifaceted needs will improve health outcomes and enhance QoL for patients undergoing RT.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Orthopedics

Country of origin: United States

Peer-review report’s classification

Scientific Quality: Grade B

Novelty: Grade C

Creativity or Innovation: Grade C

Scientific Significance: Grade B

P-Reviewer: Chen XQ S-Editor: Li L L-Editor: A P-Editor: Zhang XD
==== Refs
1 AziziKia H Teymourzadeh A Kouchaki H Nakhostin-Ansari A Jafari Doudaran P Ahmadinejad I Hoveidaei A Roshandel G Colorectal Cancer Incidence in Iran Based on Sex, Age, and Geographical Regions: A Study of 2014-2017 and Projected Rates to 2025 Arch Iran Med 2024 27 174 182 38685843
2 Hoveidaei AH Ghaseminejad-Raeini A Hosseini-Asl SH Shrestha A Hoveidaei A Taghavi SP Nwankwo BO Khonji MS Conway JD Initiating chemotherapy in joint arthroplasty patients increases the risk of periprosthetic joint infections Arch Orthop Trauma Surg 2024
3 Hoveidaei A Fekri M Hoveidaei AH Depression, the severity of bone metastasis, and the number of radiotherapy episodes: are they interlinked? Eastern J Med 2021 26 618 619
4 Jayarangaiah A Kemp AK Theetha Kariyanna P Bone Metastasis. 2023 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-
5 Jiang W Rixiati Y Zhao B Li Y Tang C Liu J Incidence, prevalence, and outcomes of systemic malignancy with bone metastases J Orthop Surg (Hong Kong) 2020 28 2309499020915989 32634071
6 Huang JF Shen J Li X Rengan R Silvestris N Wang M Derosa L Zheng X Belli A Zhang XL Li YM Wu A Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study Ann Transl Med 2020 8 482 32395526
7 Martiniakova M Mondockova V Biro R Kovacova V Babikova M Zemanova N Ciernikova S Omelka R The link between bone-derived factors osteocalcin, fibroblast growth factor 23, sclerostin, lipocalin 2 and tumor bone metastasis Front Endocrinol (Lausanne) 2023 14 1113547 36926025
8 Macedo F Ladeira K Pinho F Saraiva N Bonito N Pinto L Goncalves F Bone Metastases: An Overview Oncol Rev 2017 11 321 28584570
9 Arakil N Akhund SA Elaasser B Mohammad KS Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis Biomedicines 2024 12
10 Arvelo F Sojo F Cotte C Cancer and the metastatic substrate Ecancermedicalscience 2016 10 701 28105072
11 Akezaki Y Nakata E Kikuuchi M Sugihara S Katayama Y Katayama H Hamada M Ozaki T Factors Affecting the Quality of Life of Patients with Painful Spinal Bone Metastases Healthcare (Basel) 2021 9
12 von Moos R Costa L Ripamonti CI Niepel D Santini D Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain Eur J Cancer 2017 71 80 94 27984770
13 Burgess L Nguyen E Tseng CL Guckenberger M Lo SS Zhang B Nielsen M Maralani P Nguyen QN Sahgal A Practice and principles of stereotactic body radiation therapy for spine and non-spine bone metastases Clin Transl Radiat Oncol 2024 45 100716 38226025
14 Correia D Moullet B Cullmann J Heiss R Ermiş E Aebersold DM Hemmatazad H Response assessment after stereotactic body radiation therapy for spine and non-spine bone metastases: results from a single institutional study Radiat Oncol 2022 17 37 35189919
15 De la Pinta C SBRT in non-spine bone metastases: a literature review Med Oncol 2020 37 119 33221952
16 De Felice F Piccioli A Musio D Tombolini V The role of radiation therapy in bone metastases management Oncotarget 2017 8 25691 25699 28148890
17 Tseng YD Radiation Therapy for Painful Bone Metastases: Fractionation, Recalcification, and Symptom Control Semin Radiat Oncol 2023 33 139 147 36990631
18 Chow E Harris K Fan G Tsao M Sze WM Palliative radiotherapy trials for bone metastases: a systematic review J Clin Oncol 2007 25 1423 1436 17416863
19 Lutz S Berk L Chang E Chow E Hahn C Hoskin P Howell D Konski A Kachnic L Lo S Sahgal A Silverman L von Gunten C Mendel E Vassil A Bruner DW Hartsell W American Society for Radiation Oncology (ASTRO) Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline Int J Radiat Oncol Biol Phys 2011 79 965 976 21277118
20 Lartigau E Stereotactic body radiotherapy BMJ 2011 343 d4286 21816739
21 Chang EL Shiu AS Mendel E Mathews LA Mahajan A Allen PK Weinberg JS Brown BW Wang XS Woo SY Cleeland C Maor MH Rhines LD Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure J Neurosurg Spine 2007 7 151 160 17688054
22 Wang Z Li L Yang X Teng H Wu X Chen Z Wang Z Chen G Efficacy and safety of stereotactic body radiotherapy for painful bone metastases: Evidence from randomized controlled trials Front Oncol 2022 12 979201 36338685
23 Rich SE Chow R Raman S Liang Zeng K Lutz S Lam H Silva MF Chow E Update of the systematic review of palliative radiation therapy fractionation for bone metastases Radiother Oncol 2018 126 547 557 29397209
24 Goblirsch MJ Zwolak PP Clohisy DR Biology of bone cancer pain Clin Cancer Res 2006 12 6231s 6235s 17062706
25 Goblirsch M Mathews W Lynch C Alaei P Gerbi BJ Mantyh PW Clohisy DR Radiation treatment decreases bone cancer pain, osteolysis and tumor size Radiat Res 2004 161 228 234 14731066
26 Wu JS Wong RK Lloyd NS Johnston M Bezjak A Whelan T Supportive Care Guidelines Group of Cancer Care Ontario Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases - an evidence-based practice guideline BMC Cancer 2004 4 71 15461823
27 Sprave T Verma V Förster R Schlampp I Hees K Bruckner T Bostel T El Shafie RA Welzel T Nicolay NH Debus J Rief H Bone density and pain response following intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for vertebral metastases - secondary results of a randomized trial Radiat Oncol 2018 13 212 30376859
28 Sierko E Hempel D Zuzda K Wojtukiewicz MZ Personalized Radiation Therapy in Cancer Pain Management Cancers (Basel) 2019 11
29 Wu JS Monk G Clark T Robinson J Eigl BJ Hagen N Palliative radiotherapy improves pain and reduces functional interference in patients with painful bone metastases: a quality assurance study Clin Oncol (R Coll Radiol) 2006 18 539 544 16969984
30 Westhoff PG de Graeff A Reyners AK Monninkhof EM Rodenhuis CC van Vulpen M Leer JW Marijnen CA van der Linden YM Dutch Bone Metastasis Study Group Effect of age on response to palliative radiotherapy and quality of life in patients with painful bone metastases Radiother Oncol 2014 111 264 269 24746581
31 Westhoff PG de Graeff A Monninkhof EM Pomp J van Vulpen M Leer JW Marijnen CA van der Linden YM Dutch Bone Metastasis Study Group Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases Int J Radiat Oncol Biol Phys 2015 93 694 701 26281825
32 Zeng L Chow E Bedard G Zhang L Fairchild A Vassiliou V Alm El-Din MA Jesus-Garcia R Kumar A Forges F Tseng LM Hou MF Chie WC Bottomley A Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22 Int J Radiat Oncol Biol Phys 2012 84 e337 e342 22763028
33 McDonald R Ding K Brundage M Meyer RM Nabid A Chabot P Coulombe G Ahmed S Kuk J Dar AR Mahmud A Fairchild A Wilson CF Wu JSY Dennis K DeAngelis C Wong RKS Zhu L Chan S Chow E Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23 JAMA Oncol 2017 3 953 959 28196208
34 Mendez LC Raman S Wan BA da Silva JLP Moraes FY Lima KMLB Silva MF Diz MDPE Chow E Marta GN Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort Ann Palliat Med 2017 6 S65 S70 28595442
35 Westhoff PG Verdam MGE Oort FJ Jobsen JJ van Vulpen M Leer JWH Marijnen CAM de Graeff A van der Linden YM Dutch Bone Metastasis Study Group Course of Quality of Life After Radiation Therapy for Painful Bone Metastases: A Detailed Analysis From the Dutch Bone Metastasis Study Int J Radiat Oncol Biol Phys 2016 95 1391 1398 27315664
36 Weinfurt KP Li Y Castel LD Saad F Timbie JW Glendenning GA Schulman KA The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer Ann Oncol 2005 16 579 584 15734776
37 Zeng L Chow E Zhang L Culleton S Holden L Jon F Khan L Tsao M Barnes E Danjoux C Sahgal A Comparison of pain response and functional interference outcomes between spinal and non-spinal bone metastases treated with palliative radiotherapy Support Care Cancer 2012 20 633 639 21476118
38 Khan L Uy C Nguyen J Chow E Zhang L Zeng L Salvo N Culleton S Jon F Wong K Danjoux C Tsao M Barnes E Sahgal A Holden L Self-reported rates of sleep disturbance in patients with symptomatic bone metastases attending an outpatient radiotherapy clinic J Palliat Med 2011 14 708 714 21554034
39 Jamora KE Castillo MRL Calaguas MJC Assessment of the prevalence of pain, adequacy of pain management and influencing factors in patients undergoing radiotherapy Ecancermedicalscience 2022 16 1483 36819795
40 Arias F Arrarás JI Asín G Zarandona U Mora I Errasti M Barrado M Campo M Visus I Dominguez MA To What Extent Does Radiotherapy Improve the Quality of Life of Patients With Bone Metastasis?: A Prospective, Single-Institutional Study Am J Clin Oncol 2018 41 163 166 26535991
41 Cañón V Gómez-Iturriaga A Casquero F Rades D Navarro A Del Hoyo O Morillo V Willisch P López-Guerra JL Illescas-Vacas A Ciervide R Martinez-Indart L Cacicedo J Quality of life improvement in patients with bone metastases undergoing palliative radiotherapy Rep Pract Oncol Radiother 2022 27 428 439 36186707
42 Wong E Chow E Zhang L Bedard G Lam K Fairchild A Vassiliou V Alm El-Din MA Jesus-Garcia R Kumar A Forges F Tseng LM Hou MF Chie WC Bottomley A Factors influencing health related quality of life in cancer patients with bone metastases J Palliat Med 2013 16 915 921 23819731
43 Simon JM [Gross tumor volume and clinical target volume in radiotherapy: bone metastasis] Cancer Radiother 2001 5 704 710 11715322
44 Saito AI Hirai T Inoue T Hojo N Kawai S Kato Y Ito K Kato M Ozawa Y Shinjo H Toda K Yoshimura RI Time to Pain Relapse After Palliative Radiotherapy for Bone Metastasis: A Prospective Multi-institutional Study Anticancer Res 2023 43 865 873 36697080
45 Makita K Hamamoto Y Kanzaki H Nagasaki K Kozuki T Local control of bone metastasis treated with palliative radiotherapy in patients with lung cancer: An observational retrospective cohort study Oncol Lett 2023 26 303 37323814
46 Jain PN Chatterjee A A Randomized Placebo-Controlled Trial Evaluating the Analgesic Effect of Salmon Calcitonin in Refractory Bone Metastasis Pain Indian J Palliat Care 2020 26 4 8 32132775
47 Azmy AM Adel AM Nagy AA Ibrahim SA Comparison between Single Fraction versus Multiple Fraction Radiotherapy in Terms of Pain Control and Prevention of Skeletal Related Events in Patients with Bone Metastasis Candidates for Radiotherapy QJM 2020 113
48 Dong ZF Qin YD Wang XH [Clinical Observation of Internal Radiotherapy with Strontium-89 and 99Tc-MDP in Treatment for Pain Relief of Lung Cancer Patients with Bone Metastasis] Biaoji Mianyi Fenxi Yu Linchuang 2012 19 197 200
49 Shibata H Work-sharing between radiotherapy and chemotherapy for the treatment of bone metastasis Ann Oncol 2019 30 vi7
50 Chen L Zhu W Zhu S Ding Q Effects of alendronate combined with local radiotherapy on serum Akt/GSK3β and bone metabolism levels in patients with bone metastases from primary liver cancer Am J Transl Res 2022 14 6669 6677 36247307
51 Scorcelletti M Zange J Böcker J Sies W Lau P Mittag U Reeves ND Ireland A Rittweger J Associations between long-term exercise participation and lower limb joint and whole-bone geometry in young and older adults Front Physiol 2023 14 1150562 37250122
52 Liu Y Cao X Zhao X Shi X Lei M Qin H Quality of Life and Mental Health Status Among Cancer Patients With Metastatic Spinal Disease Front Public Health 2022 10 916004 35865242
53 Ise M Nakata E Katayama Y Hamada M Kunisada T Fujiwara T Nakahara R Takihira S Sato K Akezaki Y Senda M Ozaki T Prevalence of Psychological Distress and Its Risk Factors in Patients with Primary Bone and Soft Tissue Tumors Healthcare (Basel) 2021 9
54 Campbell KL Cormie P Weller S Alibhai SMH Bolam KA Campbell A Cheville AL Dalzell MA Hart NH Higano CS Lane K Mansfield S McNeely ML Newton RU Quist M Rauw J Rosenberger F Santa Mina D Schmitz KH Winters-Stone KM Wiskemann J Goulart J Exercise Recommendation for People With Bone Metastases: Expert Consensus for Health Care Providers and Exercise Professionals JCO Oncol Pract 2022 18 e697 e709 34990293
55 Weng Hong C Ajit Singh V Amar Singh AK Psychological disorders in patients with orthopaedic oncological diseases and their coping strategies J Orthop Surg (Hong Kong) 2022 30 10225536221093431 35410527
56 Caissie A Zeng L Nguyen J Zhang L Jon F Dennis K Holden L Culleton S Koo K Tsao M Barnes E Danjoux C Sahgal A Simmons C Chow E Assessment of health-related quality of life with the European Organization for Research and Treatment of Cancer QLQ-C15-PAL after palliative radiotherapy of bone metastases Clin Oncol (R Coll Radiol) 2012 24 125 133 21917431
57 Nipp RD Greer JA El-Jawahri A Moran SM Traeger L Jacobs JM Jacobsen JC Gallagher ER Park ER Ryan DP Jackson VA Pirl WF Temel JS Coping and Prognostic Awareness in Patients With Advanced Cancer J Clin Oncol 2017 35 2551 2557 28574777
58 Epstein AS Prigerson HG O'Reilly EM Maciejewski PK Discussions of Life Expectancy and Changes in Illness Understanding in Patients With Advanced Cancer J Clin Oncol 2016 34 2398 2403 27217454
59 Greer JA Pirl WF Jackson VA Muzikansky A Lennes IT Gallagher ER Prigerson HG Temel JS Perceptions of health status and survival in patients with metastatic lung cancer J Pain Symptom Manage 2014 48 548 557 24680623
60 El-Jawahri A Traeger L Park ER Greer JA Pirl WF Lennes IT Jackson VA Gallagher ER Temel JS Associations among prognostic understanding, quality of life, and mood in patients with advanced cancer Cancer 2014 120 278 285 24122784
61 Temel JS Greer JA Muzikansky A Gallagher ER Admane S Jackson VA Dahlin CM Blinderman CD Jacobsen J Pirl WF Billings JA Lynch TJ Early palliative care for patients with metastatic non-small-cell lung cancer N Engl J Med 2010 363 733 742 20818875
62 Temel JS Greer JA Admane S Gallagher ER Jackson VA Lynch TJ Lennes IT Dahlin CM Pirl WF Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care J Clin Oncol 2011 29 2319 2326 21555700
63 Hagan TL Fishbein JN Nipp RD Jacobs JM Traeger L Irwin KE Pirl WF Greer JA Park ER Jackson VA Temel JS Coping in Patients With Incurable Lung and Gastrointestinal Cancers: A Validation Study of the Brief COPE J Pain Symptom Manage 2017 53 131 138 27725249
64 Thureau S Faivre JC Assaker R Biver E Confavreux CB Debiais F Duterque-Coquillaud M Giammarile F Heymann D Lecouvet FE Morardet L Paycha F Body JJ Vieillard MH Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper J Bone Oncol 2020 22 100291 32292693
65 van de Haar J Hoes LR Coles CE Seamon K Fröhling S Jäger D Valenza F de Braud F De Petris L Bergh J Ernberg I Besse B Barlesi F Garralda E Piris-Giménez A Baumann M Apolone G Soria JC Tabernero J Caldas C Voest EE Caring for patients with cancer in the COVID-19 era Nat Med 2020 26 665 671 32405058
66 Yerramilli D Xu AJ Gillespie EF Shepherd AF Beal K Gomez D Yamada J Tsai CJ Yang TJ Palliative Radiation Therapy for Oncologic Emergencies in the Setting of COVID-19: Approaches to Balancing Risks and Benefits Adv Radiat Oncol 2020 5 589 594 32363243
67 Arsenijević T Stepanović A Milošević-Maračić B Poparić-Bandjur B Mišković I Gavrilović D Nikitović M What did COVID-19 pandemics teach us about single-fraction radiotherapy for painful bone metastases-State of the art or undertreatment? Cancer Med 2023 12 15912 15921 37317639
68 Chow R Ding K Ganesh V Meyer RM van der Linden YM Roos D Hartsell WF Hoskin P Wu JSY Nabid A van Acht M Wanders R Babington S Demas WF Wilson CF Wong RKS Brundage M Zhu L Chow E Gender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trial Radiother Oncol 2018 126 541 546 29102263
69 Koo K Zeng L Chen E Zhang L Culleton S Dennis K Caissie A Nguyen J Holden L Jon F Tsao M Barnes E Danjoux C Sahgal A Chow E Do elderly patients with metastatic cancer have worse quality of life scores? Support Care Cancer 2012 20 2121 2127 22081058
70 Ariyafar T Mahdavi SR Geraily G Fadavi P Farhood B Najafi M Ashouri A Khalafi L Shirazi A Evaluating the effectiveness of combined radiotherapy and hyperthermia for the treatment response of patients with painful bony metastases: A phase 2 clinical trial J Therm Biol 2019 84 129 135 31466745
71 Geerling JI Raijmakers N Mul VE de Nijs EJ Oudhof MA de Bock GH De Graeff A van der Linden YM Reyners AK The effect of nurse-led pain education of patients with painful bone metastases on pain and quality of life: A multicenter randomized trial J Clin Oncol 2017 35 203 203
72 Lutz S Balboni T Jones J Lo S Petit J Rich SE Wong R Hahn C Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline Pract Radiat Oncol 2017 7 4 12 27663933
73 Feyer PC Steingraeber M Radiotherapy of Bone Metastasis in Breast Cancer Patients - Current Approaches Breast Care (Basel) 2012 7 108 112 22740796
74 Gutt R Dawson G Cheuk AV Fosmire H Moghanaki D Kelly M Jolly S Palliative Radiotherapy for the Management of Metastatic Cancer: Bone Metastases, Spinal Cord Compression, and Brain Metastases Fed Pract 2015 32 Suppl 4 12S 16S
75 Tharmalingam S Chow E Harris K Hird A Sinclair E Quality of life measurement in bone metastases: A literature review J Pain Res 2008 1 49 58 21197288
76 Colosia A Njue A Bajwa Z Dragon E Robinson RL Sheffield KM Thakkar S Richiemer SH The Burden of Metastatic Cancer-Induced Bone Pain: A Narrative Review J Pain Res 2022 15 3399 3412 36317162
77 Selvaggi G Scagliotti GV Management of bone metastases in cancer: a review Crit Rev Oncol Hematol 2005 56 365 378 15978828
78 Vinay R KusumDevi V Potential of targeted drug delivery system for the treatment of bone metastasis Drug Deliv 2016 23 21 29 24839990
79 Chow E Hoskin P Mitera G Zeng L Lutz S Roos D Hahn C van der Linden Y Hartsell W Kumar E International Bone Metastases Consensus Working Party Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases Int J Radiat Oncol Biol Phys 2012 82 1730 1737 21489705
80 Lin A Ray ME Targeted and systemic radiotherapy in the treatment of bone metastasis Cancer Metastasis Rev 2006 25 669 675 17160556
